non-structural membrane protein K15 is required for viral lytic replication and may represent a therapeutic target. PLoS Pathog. 2017; 3(9): e1006639. doi: 10.1371/journal.ppat.1006639 Mariggiò G, Koch S

Publikationen der letzten fünf Jahre: Items 1-15 of 15 ( Display the 15 citations in PubMed ) 1. A therapeutic antigen-presenting cell-targeting DNA vaccine VB10.16 in HPV16-positive high-grade cervical in

and γδ T-cell responses to Epstein-Barr Virus: insights in immunocompetence, immune failure and therapeutic augmentation in transplant patients. Current opinion in immunology, 82, 102305. Advance online

24-03430-y. Epub ahead of print. Barlage L, Seifert R . Insufficient compliance of the German Therapeutic Products Advertising Act in product catalogues of online pharmacies. Naunyn Schmiedebergs Arch [...] 23-02796-9. Tiligada E, Stefanaki C, Ennis M, Neumann D . Opportunities and challenges in the therapeutic exploitation of histamine and histamine receptor pharmacology in inflammation-driven disorders

Rehn V, Yang Y, Bähre H , von der Ohe J, Hass R. Taxol-Loaded MSC-Derived Exosomes Provide a Therapeutic Vehicle to Target Metastatic Breast Cancer and Other Carcinoma Cells. Cancers (Basel). 2019; 11:

Bauersachs J, Thum T, Sedding DG. Senescence-induced inflammation: An important player and key therapeutic target in atherosclerosis. Eur Heart J. 2020. https://pubmed.ncbi.nlm.nih.gov/31898722 Tongers

(WSG) reports first data from the WSG-ADAPT trial (RunIn phase) for HR+/HER2- breast cancer in Therapeutic advances in medical oncology : https://pubmed.ncbi.nlm.nih.gov/33281950/ (Nov 2020) Our study on

(2024). Polysialic acid-Siglec immune checkpoints of microglia and macrophages: perspectives for therapeutic intervention. Neural Regen Res. 21 (2):661-662. doi: 10.4103/NRR.NRR-D-24-01195. Möhn N , Hounchonou

R., Koenecke, C., & Schultze-Florey, C. R. (2022). Spectral flow cytometry cluster analysis of therapeutic donor lymphocyte infusions identifies T cell subsets associated with outcome in patients with AML [...] Oncol. 2012 Jul 10;30(20):2475-82. Epub 2012 May 14. PubMed PMID: 22585692. Prinz I, Koenecke C. Therapeutic potential of induced and natural FoxP3(+) regulatory T cells for the treatment of Graft-versus-host

032485. Identification of galectin-3 as a novel potential prognostic/predictive biomarker and therapeutic target for cerebral cavernous malformation disease Kar S, Perrelli A, Bali KK, Mastrocola R, Kar